Program - Novartis Mini Oral: LEQVIO (inclisiran) through time: Key takeaways from ORION-8

Novartis Mini Oral: LEQVIO (inclisiran) through time: Key takeaways from ORION-8

Saturday, August 3, 2024

10:10 AM - 10:30 AM

Theatrette 7

Details

The session will recap the latest ORION-8 data, highlighting the proportion of patients who reach and maintain their LDL-C target with LEQVIO (inclisiran) and its long-term safety profile. Additionally, there will be a brief overview of LEQVIO patient selection, followed by a Q&A segment to address any questions.

You need to enable JavaScript to access this site.

Follow these instructions on how to enable JavaScript.

Internet Explorer

Select Tools from the top menu
Choose Internet Options
Click on the Security tab
Click on Custom Level
Scroll down until you see the section labelled Scripting
Under Active Scripting, select Enable and click OK

Google Chrome

Select the menu icon on the browser toolbar
Select Settings
Click the Show advanced settings... link then Content Settings in the Privacy section
Select Allow all sites to run JavaScript (recommended) and click Done

Safari (Mac)

Select Safari from the top menu
Choose Preferences
Choose Security
Select the checkbox next to Enable JavaScript